Related Experiment Video
Updated: Jun 11, 2025

Pseudomonas aeruginosa Induced Lung Injury Model
Published on: October 29, 2014
The battle within: how Pseudomonas aeruginosa uses host-pathogen interactions to infect the human lung
Carmen Mesas Vaz1, Alba Guembe Mülberger1, Marc Torrent Burgas1
1The Systems Biology of Infection Lab, Department of Biochemistry and Molecular Biology, Biosciences Faculty, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
Abstract:
Pseudomonas aeruginosa is a versatile Gram-negative pathogen known for its ability to invade the respiratory tract, particularly in cystic fibrosis patients. This review provides a comprehensive analysis of the multifaceted strategies for colonization, virulence, and immune evasion used by P. aeruginosa to infect the host. We explore the extensive protein arsenal of P. aeruginosa, including adhesins, exotoxins, secreted proteases, and type III and VI secretion effectors, detailing their roles in the infective process. We also address the unique challenge of treating diverse lung conditions that provide a natural niche for P. aeruginosa on the airway surface, with a particular focus in cystic fibrosis. The review also discusses the current limitations in treatment options due to antibiotic resistance and highlights promising future approaches that target host-pathogen protein-protein interactions. These approaches include the development of new antimicrobials, anti-attachment therapies, and quorum-sensing inhibition molecules. In summary, this review aims to provide a holistic understanding of the pathogenesis of P. aeruginosa in the respiratory system, offering insights into the underlying molecular mechanisms and potential therapeutic interventions.
Insights
Pseudomonas aeruginosa employs diverse strategies to infect the respiratory tract, especially in cystic fibrosis. New therapies targeting host-pathogen interactions offer hope against antibiotic resistance.
Area of Science:
- Microbiology
- Immunology
- Pulmonology
Background:
- Pseudomonas aeruginosa is a Gram-negative pathogen frequently infecting the respiratory tract.
- Cystic fibrosis patients are particularly susceptible to P. aeruginosa lung infections.
- The airway surface provides a niche for P. aeruginosa colonization.
Purpose of the Study:
- To comprehensively analyze P. aeruginosa's strategies for respiratory tract infection.
- To detail the roles of P. aeruginosa's protein arsenal in pathogenesis.
- To explore therapeutic interventions for P. aeruginosa lung infections.
Main Methods:
- Literature review of P. aeruginosa pathogenesis.
- Analysis of P. aeruginosa virulence factors and secretion systems.
- Examination of current and future therapeutic strategies.
Main Results:
- P. aeruginosa utilizes adhesins, toxins, proteases, and secretion systems for infection.
- Antibiotic resistance limits current treatment options.
- Host-pathogen protein-protein interaction-targeted therapies show promise.
Conclusions:
- P. aeruginosa exhibits complex mechanisms for respiratory colonization and immune evasion.
- Novel therapeutic approaches are needed to combat P. aeruginosa infections.
- Targeting host-pathogen interactions is a key future strategy.
More Related Videos
Related Concept Videos
Pneumonia II: Pathophysiology
Gene Regulation in Microbial Communities: Quorum Sensing
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

